4.5 Article

Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity

Journal

ACS MEDICINAL CHEMISTRY LETTERS
Volume 11, Issue 1, Pages 16-22

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.9b00462

Keywords

Neurotensin receptor; carbamoylated arginine; fluorescence labeling; flow cytometry; high-content imaging; confocal microscopy

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [KE 1857/1-1, KE 1857/1-2]
  2. DFG [GRK 1910]
  3. International Doctoral Program Receptor Dynamics Elite Network of Bavaria
  4. BBSRC [1644276] Funding Source: UKRI

Ask authors/readers for more resources

Fluorescence-labeled receptor ligands have emerged as valuable molecular tools, being indispensable for studying receptor-ligand interactions by fluorescence-based techniques such as high-content imaging, fluorescence microscopy, and fluorescence polarization. Through application of a new labeling strategy for peptides, a series of fluorescent neurotensin(8-13) derivatives was synthesized by attaching red-emitting fluorophores (indolinium- and pyridinium-type cyanine dyes) to carbamoylated arginine residues in neurotensin(8-13) analogues, yielding fluorescent probes with high NTS1R affinity (pKi values: 8.15-9.12) and potency (pEC(50) values (Ca2+ mobilization): 8.23-9.43). Selected fluorescent ligands were investigated by flow cytometry and high-content imaging (saturation binding, kinetic studies, and competition binding) as well as by confocal microscopy using intact CHO-hNTS(1)R cells. The study demonstrates the applicability of the fluorescent probes as molecular tools to obtain, for example, information about the localization of receptors in cells and to determine binding affinities of nonlabeled ligands.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Binding pathway determines norepinephrine selectivity for the human β1AR over β2AR

Xinyu Xu, Jonas Kaindl, Mary J. Clark, Harald Hubner, Kunio Hirata, Roger K. Sunahara, Peter Gmeiner, Brian K. Kobilka, Xiangyu Liu

Summary: Beta adrenergic receptors mediate physiological responses to catecholamines epinephrine and norepinephrine, and norepinephrine shows higher affinity for beta(1)AR. Crystal structure analysis revealed identical catecholamine-binding pockets but differences in extracellular vestibules between beta(1)AR and beta(2)AR, influencing norepinephrine binding path and affinity.

CELL RESEARCH (2021)

Article Biochemistry & Molecular Biology

Homobivalent Dopamine D2 Receptor Ligands Modulate the Dynamic Equilibrium of D2 Monomers and Homo- and Heterodimers

Tamara Ullmann, Marie Gienger, Julian Budzinski, Jan Hellmann, Harald Huebner, Peter Gmeiner, Dorothee Weikert

Summary: The study synthesized homobivalent ligands that promote D2R homodimerization and reduce interactions between D2R and NTSR1. These newly developed bivalent ligands are useful tools for understanding the pharmacological consequences of D2R homo- and heterodimerization.

ACS CHEMICAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Analysis of Sequence Divergence in Mammalian ABCGs Predicts a Structural Network of Residues That Underlies Functional Divergence

James I. Mitchell-White, Thomas Stockner, Nicholas Holliday, Stephen J. Briddon, Ian D. Kerr

Summary: Members of the mammalian G subfamily of ATP-binding cassette transporters exhibit significant differences in substrate specificity, with ABCG2 playing a crucial role in multidrug resistance due to its wide substrate specificity. Analysis of conservation differences between members in a multiple sequence alignment of ABCG sequences from mammals reveals possible explanations for functional differences. Mapping sets of residues onto the 3D structure of ABCG2 illustrates a network of residues that may confer additional conformational flexibility, allowing for transport of a wider array of substrates.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Optimizing the Expression of Human Dopamine Receptors in Escherichia coli

Vanessa Boritzki, Harald Hubner, Anni Allikalt, Peter Gmeiner, Birgitta M. Wohrl

Summary: The study focused on expressing human dopamine receptors D-2S and D-3 in Escherichia coli using different fusion proteins and mutations to optimize expression and evaluate ligand binding. Results showed that the presence of a C-terminal fusion protein, but not the type, is important for receptor expression. Improved receptor variants with high affinity ligand binding can be selected using FACS analysis and error-prone PCR.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Medicinal

Abolishing Dopamine D2long/D3 Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H2 Receptor Agonists

Katharina Tropmann, Merlin Bresinsky, Lisa Forster, Denise Moennich, Armin Buschauer, Hans-Joachim Wittmann, Harald Huebner, Peter Gmeiner, Steffen Pockes, Andrea Strasser

Summary: Novel carbamoylguanidine-type ligands were designed, synthesized, and tested for their selectivity as H2R agonists, revealing promising candidates and providing a basis for further exploration of H2R functions in the brain.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Visualization of β-adrenergic receptor dynamics and differential localization in cardiomyocytes

Marc Bathe-Peters, Philipp Gmach, Horst-Holger Boltz, Jurgen Einsiedel, Michael Gotthardt, Harald Huebner, Peter Gmeiner, Martin J. Lohse, Paolo Annibale

Summary: Two beta-adrenergic receptor subtypes, beta(1) and beta(2), show different localizations and diffusions in cardiomyocytes, with the segregation depending on the development of the T-tubular network, leading to distinct signaling and functional effects.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biology

Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer

Julian Budzinski, Simone Maschauer, Hiroyuki Kobayashi, Pierre Couvineau, Hannah Vogt, Peter Gmeiner, Anna Roggenhofer, Olaf Prante, Michel Bouvier, Dorothee Weikert

Summary: The study demonstrates specific interactions between dopamine D3 receptor and neurotensin receptor 1 using bivalent ligands, showing potential role of dimerization in vivo. The bivalent ligands enhance and stabilize the receptor-receptor interaction, resulting in specific receptor trafficking and signaling.

COMMUNICATIONS BIOLOGY (2021)

Article Multidisciplinary Sciences

Activation and allosteric regulation of the orphan GPR88-Gi1 signaling complex

Geng Chen, Jun Xu, Asuka Inoue, Maximilian F. Schmidt, Chen Bai, Qiuyuan Lu, Peter Gmeiner, Zheng Liu, Yang Du

Summary: This study reports two structures of the human GPR88-Gi complex, revealing an allosteric ligand involved in the interaction between the receptor and G-protein, and a potential endogenous ligand of GPR88.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Development of fluorescent peptide G protein-coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators

James P. Farmer, Shailesh N. Mistry, Charles A. Laughton, Nicholas D. Holliday

Summary: This study developed fluorescent-labeled peptides as novel binding and activation biosensors for the GPCR-IAM site, allowing the assessment of the affinity of unlabeled ligands for the receptor and providing a new method for screening IAMs. Moreover, this method can be used to investigate the efficacy of orthosteric agonists and the dynamics of receptor activation.

FASEB JOURNAL (2022)

Article Chemistry, Medicinal

Synthesis, Characterization, and Application of Muscarinergic M3 Receptor Ligands Linked to Fluorescent Dyes

Johannes Koeckenberger, Oliver Fischer, Andreas Konopa, Sebastian Bergwinkl, Susanne Muehlich, Peter Gmeiner, Roger Jan Kutta, Harald Huebner, Max Keller, Markus R. Heinrich

Summary: Two novel tool compounds, OFH5503 and OFH611, have been developed by linking fluorescent dyes and muscarinergic M-3 receptor ligands. These conjugates can be useful tools for determining binding affinities and studying receptor expression.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor

Jun Xu, Qinggong Wang, Harald Huebner, Yunfei Hu, Xiaogang Niu, Haoqing Wang, Shoji Maeda, Asuka Inoue, Yuyong Tao, Peter Gmeiner, Yang Du, Changwen Jin, Brian K. Kobilka

Summary: In this study, the authors used cryo-EM and NMR to investigate the mechanisms underlying the signaling versatility of M2R. They found that acetylcholine stabilizes a more heterogeneous M2R-G-protein complex than iperoxo, and LY2119620 modulates agonist efficacy in G-protein and beta-arrestin pathways differently. These findings highlight the importance of conformational dynamics in the complex signaling behavior of GPCRs.

NATURE COMMUNICATIONS (2023)

Article Chemistry, Medicinal

Discovery of 2-Aminopyrimidines as Potent Agonists for the Bitter Taste Receptor TAS2R14

Lukas Waterloo, Harald Hubner, Fabrizio Fierro, Tara Pfeiffer, Regine Brox, Stefan Loeber, Dorothee Weikert, Masha Y. Niv, Peter Gmeiner

Summary: The TAS2R14 receptor, found in the tongue, human airway smooth muscle, and other tissues, is a potential target for asthma and chronic obstructive pulmonary disease treatment. By modifying the structure of flufenamic acid, we developed a set of promising TAS2R14 agonists, particularly ligand 28.1, which showed higher potency and selectivity compared to flufenamic acid and other taste receptors.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Exploring Structural Determinants of Bias among D4 Subtype-Selective Dopamine Receptor Agonists

Fabian Grassl, Leonard Bock, Alvaro Huete-Huerta Gonzalez, Martin Schiller, Peter Gmeiner, Joerg Koenig, Martin F. Fromm, Harald Huebner, Markus R. Heinrich

Summary: Based on APH199, two novel groups of D-4 subtype selective ligands were designed and evaluated, showing bias toward G(i) signaling pathway over β-arrestin recruitment compared to quinpirole. These compounds exhibited different bias profiles in terms of efficacy, potency, and GRK2 dependency, ranging from 1 to over 300 bias factors and activation from 15% to over 98% compared to quinpirole. Docking studies provided insights into the role of ECL2 and EPB in bias emergence, utilizing the diversity of functionally selective D-4 agonists.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Design, Synthesis, and Application of Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the CXC Chemokine Receptor 2

Bianca Maria Casella, James P. P. Farmer, Desislava N. N. Nesheva, Huw E. L. Williams, Steven J. J. Charlton, Nicholas D. D. Holliday, Charles A. A. Laughton, Shailesh N. N. Mistry

Summary: Inhibition of CXCR2 is a potential strategy for the treatment of pulmonary diseases and cancers. This study reports the design and synthesis of fluorescent NAMs that selectively bind to CXCR2, enabling the measurement and evaluation of their pharmacological properties. These NAMs can be used as alternative compounds for targeting these receptors.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Discovery of 2-Aminopyrimidines as Potent Agonists for the Bitter Taste Receptor TAS2R14

Lukas Waterloo, Harald Huebner, Fabrizio Fierro, Tara Pfeiffer, Regine Brox, Stefan Loeber, Dorothee Weikert, Masha Y. Niv, Peter Gmeiner

Summary: TAS2R14 is a bitter taste receptor found in multiple locations, including the tongue and human airway smooth muscle. Activation of TAS2R14 can lead to bronchodilation, making it a potential target for treating asthma or chronic obstructive pulmonary disease. By modifying the structure of flufenamic acid, a study identified a group of effective and potent TAS2R14 agonists called 2-aminopyridines with a tetrazole unit. The most potent ligand, 28.1, showed a six-fold higher potency than flufenamic acid and demonstrated selectivity over other human taste receptors.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

No Data Available